NurseMagic expansion and Q2 2026 revenue outlined by Amesite (NASDAQ: AMST)

Q: What does the Amesite (AMST) update say about financial strength and debt?

The materials state that Amesite has zero corporate debt and describes having an estimated six months of operating burn covered by cash on hand. Management characterizes this as good liquidity while it pursues B2B NurseMagic sales in large non-acute healthcare markets.

Q: How is Amesite (AMST) building demand and a sales pipeline for NurseMagic?

Amesite reports over 49,000 social followers since early 2024 and multiple viral posts exceeding one million views. Its funnel includes roughly 50,000 B2C prospects and around 1,000 organizations, plus active discussions with about 15 organizations representing approximately 62,000 patients in census.

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Amesite Inc. furnished updated shareholder presentation materials outlining progress of its AI-driven NurseMagic platform and broader business. The update highlights large non-acute care markets across home care, home health, hospice, senior living and skilled nursing, and describes disruptive documentation and EMR pricing starting around $1 per patient per month.

The materials note prior revenue momentum, including earlier periods with 240% and 63% revenue growth and Q2 2026 revenues of $108,050, along with a mix of B2C and B2B customers. Amesite also emphasizes having zero corporate debt, several months of operating cash coverage, growing social media reach for NurseMagic, and a sales pipeline of multi-site healthcare organizations.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Key Figures

Q2 2026 Revenue: $108,050 Prior QoQ Revenue Growth: 240% Revenue Growth Period: 63% +5 more

8 metrics

Q2 2026 Revenue $108,050 Revenues in Q2 2026

Prior QoQ Revenue Growth 240% Revenue growth quarter-over-quarter announced May 2025

Revenue Growth Period 63% Revenue growth from July 14 to September 11, 2025

Documentation Pricing $1 per patient per month Starting price for NurseMagic documentation offering

Estimated Cash Runway 6 months Estimated months of burn covered by cash on hand

Corporate Debt $0 Corporate debt level described as of December 31, 2025

NurseMagic Social Followers 49,000+ Followers since February 2024 inception across six channels

Active Prospect Census ≈62,000 patients Census across 15 organizations in active discussions

Key Terms

Regulation FD Disclosure, forward - looking statements, Private Securities Litigation Reform Act of 1995, emerging growth company, +2 more

6 terms

Regulation FD Disclosure regulatory

"Item 7.01 Regulation FD Disclosure. Amesite Inc. (the “Company”) has prepared presentation materials"

forward - looking statements regulatory

"This presentation may contain “forward - looking statements” within the meaning of Section 27A"

Private Securities Litigation Reform Act of 1995 regulatory

"safe harbor for forward - looking statements contained in the Private Securities Litigation Reform Act of 1995"

emerging growth company regulatory

"Emerging growth company Item 7.01 Regulation FD Disclosure."

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

public float financial

"As of December 31, 2025 3 Public Float Team Experience and Award"

Public float is the total number of a company's shares that are available for trading by the general public. It excludes shares held by company insiders or large stakeholders who are unlikely to sell them easily. This figure helps investors understand how much of the company's stock is actively available, which can influence its liquidity and how easily its price might change.

Nasdaq market

"Nasdaq: AMST – Broader Opportunity • A profitable wedge could reframe AMST"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

Understanding 8-K Material Events →

04/20/2026 - 08:23 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 20, 2026

Amesite Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-39553

82-3431718

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

607 Shelby Street

Suite 700 PMB 214

Detroit, MI

48226

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (734) 876-8141

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		AMST		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Amesite Inc. (the “Company”) has prepared presentation materials (the “Presentation Materials”) that management intends to use from time to time in presentations about the Company’s operations and performance. The Presentation Materials were posted to the Company’s website on April 20, 2026. The Presentation Materials are furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in any such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Presentation Materials
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMESITE INC.

Date: April 20, 2026	By:	/s/ Ann Marie Sastry, Ph.D.
	Name:	Ann Marie Sastry, Ph.D.
	Title:	Chief Executive Officer

Exhibit 99.1

Source: View Original Filing on SEC EDGAR

FAQ

What did Amesite (AMST) disclose in its April 2026 shareholder update?

Amesite shared updated presentation materials describing its NurseMagic AI platform, commercial traction and financial metrics. The update covers target markets, prior revenue growth figures, Q2 2026 revenues of $108,050, sales pipeline details, and its capital structure, including zero corporate debt and several months of cash coverage.

How is Amesite (AMST) positioning its NurseMagic platform in healthcare?

Amesite positions NurseMagic as an AI-native documentation and workflow platform for non-acute care. It targets home care, home health, hospice, senior living and skilled nursing, emphasizing reduced overhead, end-to-end documentation and EMR capabilities, and disruptive pricing starting at about $1 per patient per month for documentation.

What revenue figures did Amesite (AMST) highlight in the presentation?

Amesite highlighted prior periods of strong growth, including announced 240% revenue growth quarter-over-quarter and 63% revenue growth over a specific 2025 period. The company also reported $108,050 in revenues for Q2 2026, alongside a growing mix of B2B and B2C NurseMagic customers.

What does the Amesite (AMST) update say about financial strength and debt?

The materials state that Amesite has zero corporate debt and describes having an estimated six months of operating burn covered by cash on hand. Management characterizes this as good liquidity while it pursues B2B NurseMagic sales in large non-acute healthcare markets.

How is Amesite (AMST) building demand and a sales pipeline for NurseMagic?

Amesite reports over 49,000 social followers since early 2024 and multiple viral posts exceeding one million views. Its funnel includes roughly 50,000 B2C prospects and around 1,000 organizations, plus active discussions with about 15 organizations representing approximately 62,000 patients in census.

Which customer segments and price points does Amesite (AMST) target?

Amesite targets both individual clinicians and enterprises, including multi-site, multi-segment organizations with census above 5,000. NurseMagic offers documentation starting near $1 per patient per month and a full EMR that it says is 50–80% less expensive than legacy providers for large-scale deployments.

Filing Exhibits & Attachments

4 documents

Press Releases

EX-99.1 PRESENTATION MATERIALS 29.8 KB